GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeStance Health Group Inc (NAS:LFST) » Definitions » ROE %

LifeStance Health Group (LifeStance Health Group) ROE % : -12.47% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LifeStance Health Group ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. LifeStance Health Group's annualized net income for the quarter that ended in Dec. 2023 was $-180 Mil. LifeStance Health Group's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $1,442 Mil. Therefore, LifeStance Health Group's annualized ROE % for the quarter that ended in Dec. 2023 was -12.47%.

The historical rank and industry rank for LifeStance Health Group's ROE % or its related term are showing as below:

LFST' s ROE % Range Over the Past 10 Years
Min: -23.83   Med: -13.36   Max: Negative Equity
Current: -12.58

During the past 5 years, LifeStance Health Group's highest ROE % was Negative Equity%. The lowest was -23.83%. And the median was -13.36%.

LFST's ROE % is ranked worse than
74.02% of 612 companies
in the Healthcare Providers & Services industry
Industry Median: 4.035 vs LFST: -12.58

LifeStance Health Group ROE % Historical Data

The historical data trend for LifeStance Health Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeStance Health Group ROE % Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Negative Equity - -23.83 -14.07 -12.64

LifeStance Health Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.24 -9.06 -12.13 -16.70 -12.47

Competitive Comparison of LifeStance Health Group's ROE %

For the Medical Care Facilities subindustry, LifeStance Health Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeStance Health Group's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's ROE % distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's ROE % falls into.



LifeStance Health Group ROE % Calculation

LifeStance Health Group's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-186.262/( (1518.723+1428.93)/ 2 )
=-186.262/1473.8265
=-12.64 %

LifeStance Health Group's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-179.836/( (1455.048+1428.93)/ 2 )
=-179.836/1441.989
=-12.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


LifeStance Health Group  (NAS:LFST) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-179.836/1441.989
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-179.836 / 1122.412)*(1122.412 / 2142.5175)*(2142.5175 / 1441.989)
=Net Margin %*Asset Turnover*Equity Multiplier
=-16.02 %*0.5239*1.4858
=ROA %*Equity Multiplier
=-8.39 %*1.4858
=-12.47 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-179.836/1441.989
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-179.836 / -153.264) * (-153.264 / -129.084) * (-129.084 / 1122.412) * (1122.412 / 2142.5175) * (2142.5175 / 1441.989)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.1734 * 1.1873 * -11.5 % * 0.5239 * 1.4858
=-12.47 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


LifeStance Health Group ROE % Related Terms

Thank you for viewing the detailed overview of LifeStance Health Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeStance Health Group (LifeStance Health Group) Business Description

Traded in Other Exchanges
N/A
Address
4800 North Scottsdale Road, Suite 6000, Scottsdale, AZ, USA, AZ 85251
LifeStance Health Group Inc is a provider of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions.
Executives
Kevin Michael Mullins officer: Chief Development Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Paula Cipollone officer: See Remarks 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Warren Gouk officer: Chief Administrative Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Ann Varanakis officer: Chief People Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Anisha Patel-dunn officer: Chief Medical Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Ryan Pardo officer: See Remarks 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Danish J. Qureshi officer: Chief Growth Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Pablo Pantaleoni officer: Chief Digital Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Kenneth A Burdick director, officer: Chief Executive Officer 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Felicia Gorcyca officer: Chief People Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Michael K. Lester director, officer: See Remarks 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Gwen H. Booth officer: Chief Operating Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Jesse Michael Bruff officer: Chief Financial Officer 3100 HANSEN WAY, PALO ALTO CA 94304
Tpg Gp A, Llc 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102